Articles tagged with Eye Diseases
Researchers will pinpoint the genetic cause of Thiel-Behnke, a rare corneal dystrophy, using a $1.1 million NEI grant. The study aims to improve diagnosis and treatment options for other types of corneal dystrophies.
A clinical trial found that daily and weekend administration of atropine sulfate eye drops have similar improvement in children with amblyopia, a condition affecting 3% of US children. The study suggests weekend drops may relieve parent burden while encouraging treatment compliance.
Researchers found that atropine eye drops administered two days a week are as effective as daily drops or an eye patch in treating amblyopia. This reduces hassle for young patients, enabling better vision development.
A growing epidemic of wet AMD is expected to double diagnoses by 2020, with new treatments in late-phase clinical trials or pending FDA approval showing promise for stabilizing the disease and preserving vision. Innovations in biotechnology offer new options for patients, including anti-VEGF, anti-angiogenic, and angiostatic treatments.
Researchers successfully transplanted human retinal stem cells into light-sensing photoreceptor cells and retinal pigment epithelial cells in animal models. The study's findings have implications for future treatment of degenerative eye diseases such as retinitis pigmentosa and macular degeneration.
The study confirms that patients benefit from two years of treatment with Macugen for wet AMD, demonstrating a statistically significant 45% treatment benefit. Longer-term use may be beneficial for patients suffering from this chronic disease.
The Schepens Eye Research Institute will combine forces with experts from other biomedical and technological fields to develop a center for curing eye diseases, including age-related macular degeneration and diabetic retinopathy. The three-year grant will fund the planning and piloting phase of an interdisciplinary research center.
A new technique using spectral imaging allows doctors to detect and chart eye diseases such as diabetic retinopathy and glaucoma with high accuracy. The method uses liquid crystal tuneable filters and cooled digital cameras to take images at specific wavelengths, revealing the oxygenation state of blood vessels in the eye.
This September 2004 issue of Ophthalmology journal features groundbreaking research on predictive factors for glaucomatous visual field progression, primary open-angle glaucoma in Japan, and hypothyroidism's impact on open-angle glaucoma. The studies also explore the mechanism of ocular hypotensive action of bimatoprost and optic nerve...
A new study by USC researchers reveals high levels of visual impairment and eye disease among Latinos, with nearly one in four participants having diabetes and nearly half showing signs of diabetic retinopathy. The study also found that open-angle glaucoma and ocular hypertension were prevalent among the Latino population.
A comprehensive study found that US Latinos have high rates of diabetic retinopathy, open-angle glaucoma, and cataract, with significant disparities in healthcare access. Researchers emphasize the importance of providing culturally tailored programs to detect and manage eye diseases in this population.
The study reveals alarming rates of eye diseases among Latinos, including open-angle glaucoma, diabetic retinopathy, and cataracts. These findings underscore the importance of developing tailored prevention and treatment strategies for this underserved population.
The American Academy of Ophthalmology published significant studies in the July 2004 issue, shedding light on innovative treatments and technologies for various eye conditions. These groundbreaking findings have the potential to transform the field of ophthalmology and improve patient outcomes.
A study reveals that 97% of infertile couples and 80% of the general population believe PGD should be permitted for detecting genetic diseases. The majority also oppose reproductive cloning, with only 7% in favour. Germans demand change in German Embryo Protection Law to allow PGD.
African American participants who received pressure-lowering eye drops had a lower risk of developing glaucoma compared to those who didn't receive treatment. Regular eye exams are crucial for determining glaucoma risk, particularly in African Americans over 40.
A new study published in Archives of Ophthalmology suggests that daily eye drops can significantly reduce the development of primary open-angle glaucoma in African Americans by nearly 50%. The study recommends periodic eye exams starting at age 40 for high-risk individuals.
The study found that daily pressure-lowering eye drops reduced the development of primary open-angle glaucoma in African Americans by almost 50%. This suggests that comprehensive dilated eye examinations should be recommended at least once every two years for African Americans over age 40.
A recent study found that fruit consumption was inversely associated with risk of neovascular ARM, a more severe type of vision loss. Participants who ate three or more servings per day had a 36% lower risk compared to those eating less than 1.5 servings.
This June 2004 Ophthalmology Journal issue presents various studies on retinal detachment, glaucoma valve implantation, and age-related maculopathy. The efficacy and safety of adjunctive Mitomycin C during Ahmed Glaucoma Valve Implantation are also examined.
Glaucoma is a group of disorders that progressively damage the optic nerve, affecting 66 million people worldwide. Early detection through comprehensive eye assessments, including optic disc examination, is crucial for limiting vision loss and advancing treatment. Current therapies can limit vision loss if identified in early stages.
Researchers have identified six essential genes for cilia formation in humans, which could help diagnose and treat diseases such as infertility, pulmonary diseases, and vision problems. The discovery provides a critical new tool for medical researchers to understand the genetic basis of these disorders.
Researchers from the National Eye Institute investigated the association between various types of visual impairment and eye disorders with mortality. The study found that participants with AMD had a 41% higher risk of death compared to those with little or no drusen, while advanced AMD was associated with cardiovascular deaths.
A study by the Eye Diseases Prevalence Research Group found that approximately two-fifths of persons aged 40 and older with DM are affected by diabetic retinopathy, while one in twelve have reached a vision-threatening stage. The prevalence rates were estimated using data from eight population-based eye surveys.
The study found that approximately one-third of people older than 40 experience vision disturbances, with myopia being the most prevalent eye disorder. The estimated prevalence rates for myopia vary by region, affecting about one in four people in the US and Western Europe, and one in six Australians.
The prevalence of age-related macular degeneration (AMD) is estimated to be 1.47% in the US population aged 40 and older, with an expected increase to 2.95 million cases by 2020. The risk of AMD increases dramatically with age, especially among white individuals.
The prevalence of cataracts among Americans over 40 is estimated at 17.2%, with 20.5 million affected, and expected to rise to 30.1 million by 2020. Women are almost 40% more likely to develop cataract than men.
A study estimates that 937,000 Americans are blind, with white persons affected by age-related macular degeneration. The prevalence of visual impairment is expected to increase due to aging, with blacks and Hispanics more likely to be affected by cataracts and glaucoma.
The Eye Diseases Prevalence Research Group has conducted large, population-based studies to determine the prevalence of cataract, age-related macular degeneration, diabetic retinopathy, and other eye disorders. The estimates are likely to be reliable and available without waiting many years and spending tens of millions of dollars.
The study projects that vision loss from eye diseases will reach 5.5 million Americans by 2020, with age-related macular degeneration, glaucoma, and cataract being the most common causes. Regular comprehensive eye exams are crucial for preventing and/or delaying eye disease in those at higher risk.
This April 2004 journal from the American Academy of Ophthalmology presents numerous studies on eye conditions such as Mohs surgery, glaucoma intervention, cataract surgery outcomes, and more. The research findings cover a range of topics including diabetic macular edema diagnosis, retinal detachment, and keratoconic corneas.
Scientists identify site-specific growth signals that promote capillary formation in the developing retina and inner ear, providing a potential new approach for treating blinding diseases and improving treatment outcomes for conditions like cancer, heart disease, and stroke.
Scientists have discovered a key relationship between two inherited eye disorders, Norrie disease and FEVR, linked to blood vessel malformation and activation of the Wnt pathway. The study sheds light on potential treatments for these conditions and raises questions about specialized vascular development systems in other tissues.
A study of 5,924 participants aged 43 to 84 found that dry eye developed in 13.3% over a five-year period, with significant associations with age, allergy or diabetes, and poorer health. Certain medications and lifestyle factors also showed protective effects.
Research on glaucoma medication latanoprost vs. timolol shows intraocular pressure-reducing effects and safety benefits. A study on frequency-doubling perimetry also explores its feasibility in young children.
Research suggests eye disease is a risk factor for sleep disorders, particularly in patients with optic nerve disease. The study found that visually impaired subjects with optic nerve disease were nine times more likely to experience pathologic sleepiness than those with normal sight.
Children with optic nerve disease are up to 20 times more likely to experience excessive daytime sleepiness due to disruptions in their body's internal clock. Researchers found that the loss of a specific type of cell in the retina, which helps regulate light exposure, is directly linked to sleep disturbances.
Scientists are working to create an animal that lacks the genomic architecture to code for normal prions, which cause Bovine Spongiform Encephalopathy (BSE) and Creutzfeldt-Jacob Disease. The goal is to produce a cow that is genetically incapable of producing prions, which could potentially contain the risks of this disease.
This issue of the January 2004 Ophthalmology journal presents a range of studies on LASIK complications, including night vision issues and corneal epithelial adhesion abnormalities. Researchers also explore various eye diseases, such as retinal tears, glaucoma, and macular degeneration.
The American Academy of Ophthalmology published various studies on cataract surgery, glaucoma treatment, and eye diseases in December 2003. These studies examined the effectiveness of different surgical techniques and medications for treating refractive errors, glaucoma, and age-related macular degeneration.
The American Academy of Ophthalmology meeting explored approaches to preventing, treating, and living with macular degeneration. Researchers presented updates on the effect of vitamin and mineral supplementation, surgical approaches, anti-VEGF drugs like Macugen, and visual rehabilitation.
Researchers are developing a new drug to treat myasthenia gravis by targeting the nerve-muscle communication point and reducing complement activation. The study aims to provide a more effective treatment with fewer side effects than existing therapies, which have limited success due to their adverse effects.
A recent study suggests that daily vitamin supplements can reduce the risk of advanced age-related eye disease (AMD) by 25% and vision loss by 19%. Researchers estimate that 1.3 million adults may develop advanced AMD without treatment, highlighting the importance of regular retina exams.
A study found that people with glaucoma and macular degeneration had lower rates of annual eye exams compared to those with diabetes. The study suggests that changes in medical practice are necessary to improve patient compliance and prevent visual loss.
Researchers have found that injecting adult bone marrow-derived stem cells into the back of mouse eyes curtails retinal degeneration and restores normal retinal tissue. The treated mice had improved vision and responded to light, offering a potential new approach for treating retinitis pigmentosa.
A study published in the American Journal of Ophthalmology found that nearly 3.2 million women aged 50 and older in the US suffer from debilitating dry eye syndrome, which can lead to scarring, ulceration, and loss of vision. The disease is more common in women than men, with Hispanic and Asian women experiencing more severe symptoms.
Researchers have discovered a gene mutation associated with an eye disease that resembles age-related macular degeneration. The study, led by Michigan Medicine scientists, has found that the mutation in RDS can be inherited in an autosomal dominant pattern, affecting central vision and leading to permanent loss of vision.
CA4P, a vascular targeting agent, is being tested in humans for the first time to prevent and regress choroidal neovascularization, a major cause of vision loss in age-related macular degeneration. The trial is led by Johns Hopkins' Wilmer Eye Institute and funded by The Foundation Fighting Blindness, Inc.
Researchers developed VEGF-TRAP, an injection that prevents new blood vessel growth in the eyes of mice. The treatment halted existing vessel leakage and showed long-lasting effects without complications. It may offer a potential treatment for diabetic retinopathy and macular degeneration.
Researchers use eye movement tests to investigate brain abnormalities causing mental disorders, including schizophrenia, depression, and autism. The study aims to develop a noninvasive tool for diagnosing brain disorders.
Researchers found that model mice with pigment dispersion glaucoma had abnormal immune responses in their eyes, which preceded disease onset. The study suggests that loss of immune privilege may trigger the development of glaucoma.
Children with moderate amblyopia showed significant improvement in vision after four months of daily two-hour or six-hour patching. This study provides real scientific evidence for a more convenient treatment option, reducing social stigma associated with traditional patching methods.
A new study finds that patching the unaffected eye for two hours daily is as effective as patching for six hours in treating moderate amblyopia in children. The results improve visual acuity and reduce social stigma associated with treatment, making it easier for parents to monitor their child's progress.
Schepens Eye Research Institute scientists have discovered a new drug that can trap abnormal growth factors in the cornea, potentially improving corneal transplants. Additionally, a gene therapy approach has shown promise in preventing and treating autoimmune diseases like uveitis by inducing a protein called a-MSH.
A comprehensive five-year study tracked causes of blindness and access to eye care among the US Latino population, finding high rates of vision-related problems. The study revealed that Latinos have nearly 18% vision impairment by age 85 and older, with diabetes and cataracts being leading causes.
A recent study by David Heeger and David Ress of NYU found that brain activity in the visual cortex corresponds to subjects' precepts, not the physically presented stimulus. This suggests that distortions occur at the first stages of brain processing and may shed light on conditions like amblyopia.
A long-term study found that administering oral antivirals reduced the risk of blindness and other serious eye effects in patients with eye shingles. Untreated patients experienced 8.9% adverse outcomes, while treated patients had only 2.1%. Timing of treatment also affected long-term outcomes.
Using adaptive optics, researchers can now clearly see features such as blood flow in the retina, enabling early diagnosis of diseases. This technology will help eye doctors track changes in patients with conditions like diabetes and glaucoma.
Researchers found that low-level lead exposure during development in mice injures and kills rod-shaped photoreceptor cells, a crucial component of human vision. The study suggests possible treatments using an anti-death protein called Bcl-xL to prevent cell death in eye disorders.
Researchers have developed a new technology using adaptive optics to improve diagnosis of eye diseases. The technology enables doctors to see individual cells in the retina, allowing for early detection and treatment of conditions such as glaucoma and age-related macular degeneration.
A new study from the Liverpool Diabetic Eye Study has proposed optimal screening intervals for diabetic eye disease, based on incidence data. The findings suggest that patients with no baseline retinopathy should be screened every 3 years, while those with background retinopathy can be screened annually.